New antibody drug stops aggressive prostate cancer from spreading
Researchers have developed a fully human antibody drug capable of halting the growth and spread of aggressive prostate cancer in lab models.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A new generation of prostate cancer drugs has emerged, specifically a fully human antibody designed to stop aggressive forms of the disease from spreading. This development was observed in lab models.
Coverage from SciTechDaily, ScienceDaily, Medical Daily, and Futura emphasizes the promise of this new drug and its ability to halt cancer growth. Separately, Oncodaily reports that the NINJA prostate cancer trial has completed its recruitment phase.
Attention now turns to the results of the NINJA trial, which has successfully enrolled 472 participants.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
What is the nature of the new drug?
It is a fully human antibody designed to stop aggressive prostate cancer from growing and spreading.
Where has the drug been tested?
According to Medical Daily, the drug halted cancer growth and spread in lab models.
What is the status of the NINJA prostate cancer trial?
The trial has completed recruitment with 472 participants.
Coverage (5)
- Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading SciTechDaily · 15h ago
- A new generation of prostate cancer drugs is raising hope—here’s why Futura, le média qui explore le monde · 15h ago
- Researchers Develop a Fully Human Antibody That Halted Aggressive Prostate Cancer Growth and Spread in Lab Models Medical Daily · 15h ago
- Jarad Martin: NINJA Prostate Cancer Trial Completes Recruitment With 472 Participants Oncodaily · 15h ago
- New antibody drug stops aggressive prostate cancer from spreading ScienceDaily · 15h ago
Topics
Related trends
Where You Live May Shape Your Dementia Risk More Than Scientists Realized
New research suggests geographic location and zip codes may be critical indicators of dementia risk years before a diagnosis.
Scientists are regrowing human teeth
Researchers are developing regenerative dentistry technology to grow human teeth as an alternative to implants and fillings.
Too Much Happiness Sent A Woman To The Emergency Room In an Incredibly Rare Case
A rare medical occurrence known as 'Happy Heart Syndrome' has led to the hospitalization of a woman following her daughter's wedding.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
Common Digestive Drug May Help Ease Depression and Brain Fog
Research suggests a common medication used for constipation may offer relief for depression and associated brain fog.
Non-smokers under 50 are getting lung cancer. What they eat raised a red flag
Research indicates an unexpected rise in lung cancer cases among non-smokers under 50, with new attention focused on dietary risks.